A
Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
NSE:ABBOTINDIA
Price:
25 820.0508 INR
-1.19%
Market Closed
Updated:
May 6, 2024
Abbott India Ltd
Operating Income
|
Abbott India Ltd
Operating Income Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Operating Income
₹11.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹62.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹50.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹101.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹39.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹24.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Abbott India Ltd's Operating Income?
Operating Income
11.4B
INR
11.4B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Operating Income amounts to 11.4B INR.
What is Abbott India Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
17%
17%
Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Abbott India Ltd have been 17% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
